These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 2427602)

  • 1. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF).
    Breathnach SM; Katz SI
    J Invest Dermatol; 1985 Dec; 85(6):553-8. PubMed ID: 3877770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
    Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
    J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
    Cooper KD; Neises GR; Katz SI
    J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis.
    Kim BS; Miyagawa F; Cho YH; Bennett CL; Clausen BE; Katz SI
    J Invest Dermatol; 2009 Dec; 129(12):2805-17. PubMed ID: 19554018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the inducible keratinocyte expression of Ia and the movement of Langerhans cells into the epidermis.
    Roberts LK; Krueger GG; Daynes RA
    J Immunol; 1985 Jun; 134(6):3781-4. PubMed ID: 2580896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
    Steiner G; Wolff K; Pehamberger H; Stingl G
    J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical, morphological and phenotypic changes in Langerhans cells in the course of murine graft-versus-host disease.
    Asagoe K; Takahashi K; Yoshino T; Kondo E; Tanaka R; Arata J; Akagi T
    Br J Dermatol; 2001 Dec; 145(6):918-27. PubMed ID: 11899145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen.
    Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI
    J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
    Ashworth J; Booker J; Breathnach SM
    Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells.
    Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM
    J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cutaneous graft-versus-host disease by allo- or self-Ia-reactive helper T cells in mice.
    Shiohara T; Narimatsu H; Nagashima M
    Transplantation; 1987 May; 43(5):692-8. PubMed ID: 2437672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset.
    Simon JC; Cruz PD; Bergstresser PR; Tigelaar RE
    J Immunol; 1990 Oct; 145(7):2087-91. PubMed ID: 1975824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury.
    Cooper KD; Duraiswamy N; Hammerberg C; Allen E; Kimbrough-Green C; Dillon W; Thomas D
    J Invest Dermatol; 1993 Aug; 101(2):155-63. PubMed ID: 8393901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-presenting cell function of epidermal cells activated by hapten application.
    Nakano Y
    Br J Dermatol; 1998 May; 138(5):786-94. PubMed ID: 9666823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.